Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signaling

Vasohibin‐2 (VASH2) is a homolog of VASH1, an endothelium‐derived angiogenesis inhibitor. Vasohibin‐2 is mainly expressed in cancer cells, and has been implicated in the progression of cancer by inducing angiogenesis and tumor growth. Although VASH2 has been recently reported to be involved in epith...

Descripción completa

Detalles Bibliográficos
Autores principales: Norita, Rie, Suzuki, Yasuhiro, Furutani, Yutaka, Takahashi, Kazuki, Yoshimatsu, Yasuhiro, Podyma‐Inoue, Katarzyna A., Watabe, Tetsuro, Sato, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378260/
https://www.ncbi.nlm.nih.gov/pubmed/28064471
http://dx.doi.org/10.1111/cas.13157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378260/
https://www.ncbi.nlm.nih.gov/pubmed/28064471
http://dx.doi.org/10.1111/cas.13157

Ejemplares similares